BlackRock Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$274M Sell
1,872,324
-383,787
-17% -$57.8M 0.32% 60
2016
Q3
$376M Sell
2,256,111
-199,621
-8% -$33.8M 0.46% 37
2016
Q2
$374M Sell
2,455,732
-11,899
-0.5% -$1.85M 0.47% 37
2016
Q1
$370M Sell
2,467,631
-24,940
-1% -$3.71M 0.48% 36
2015
Q4
$405M Buy
2,492,571
+87,862
+4% +$13.8M 0.52% 31
2015
Q3
$333M Sell
2,404,709
-49,058
-2% -$7.73M 0.45% 44
2015
Q2
$377M Buy
2,453,767
+96,933
+4% +$15.5M 0.47% 38
2015
Q1
$377M Buy
2,356,834
+22,285
+1% +$3.51M 0.49% 35
2014
Q4
$372M Buy
2,334,549
+212,107
+10% +$33.1M 0.49% 36
2014
Q3
$298M Sell
2,122,442
-85,007
-4% -$11.1M 0.42% 45
2014
Q2
$261M Buy
2,207,449
+73,933
+3% +$8.56M 0.35% 60
2014
Q1
$263M Buy
2,133,516
+27,993
+1% +$3.4M 0.38% 51
2013
Q4
$240M Sell
2,105,523
-41,234
-2% -$4.69M 0.36% 59
2013
Q3
$240M Buy
2,146,757
+222,856
+12% +$24.2M 0.4% 50
2013
Q2
$190M Buy
+1,923,901
New +$200M 0.34% 61

Other funds holding AMGN

BlackRock Investment Management's AMGN Position: Q4 2016 in Review

BlackRock Investment Management reduced its Amgen (AMGN) stake by 17% in Q4 2016, selling an estimated $57.8M and leaving 1,872,324 shares worth $274M. The position accounts for 0.32% of the portfolio, ranked #60.

BlackRock Investment Management first reported a position in AMGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $405M in Q4 2015. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • BlackRock Investment Management held 1,872,324 shares of Amgen worth $274M as of Q4 2016.
  • BlackRock Investment Management sold 383,787 Amgen shares in Q4 2016, an estimated $57.8M.
  • Amgen made up 0.32% of BlackRock Investment Management's portfolio in Q4 2016, its #60 holding.
  • BlackRock Investment Management first reported a position in Amgen in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Amgen position peaked at $405M in Q4 2015.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.